Balyasny Asset Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-127,887
| Closed | -$353K | – | 2460 |
|
|
2025
Q1 | $353K | Buy |
+127,887
| New | +$353K | ﹤0.01% | 1661 |
|
|
2024
Q3 | – | Sell |
-19,161
| Closed | -$130K | – | 2353 |
|
|
2024
Q2 | $130K | Buy |
+19,161
| New | +$130K | ﹤0.01% | 1750 |
|
|
2024
Q1 | – | Sell |
-13,854
| Closed | -$89.9K | – | 2425 |
|
|
2023
Q4 | $89.9K | Buy |
+13,854
| New | +$89.9K | ﹤0.01% | 1820 |
|
|
2023
Q3 | – | Sell |
-583,651
| Closed | -$5.11M | – | 2201 |
|
|
2023
Q2 | $5.11M | Buy |
583,651
+215,980
| +59% | +$1.89M | 0.01% | 767 |
|
|
2023
Q1 | $4.35M | Buy |
+367,671
| New | +$4.35M | 0.01% | 847 |
|
|
2021
Q3 | – | Sell |
-10,308
| Closed | -$126K | – | 2076 |
|
|
2021
Q2 | $126K | Buy |
+10,308
| New | +$126K | ﹤0.01% | 1493 |
|